Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STSP-0601 in Patients With Inhibitory Hemophilia
NCT05027230Phase 2Completed
- Sponsor
- Staidson Biopharmaceutical
- Start
- Oct 2021
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bemiltenase alfa in hemophilia A, hemophilia B (HB), sponsored by Staidson Biopharmaceutical. Started Oct 2021; status: completed.
02
Drugs
bemiltenase alfa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT05027230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027230.